The spatial organization of proteins within cells defines biological function, yet until recently, the proteomic tools available to study this organization have been limited by scale and specificity. The Syncell Microscoop platform introduces nanoscopic proteomics – a new frontier in discovery that combines high-precision optical targeting with unbiased proteomic identification to reveal molecular organization at unprecedented resolution.
Dr Jung-Chi Liao founded SYNCELL in 2020 with the optoproteomics technology invented in his lab at Academia Sinica in Taiwan. Under his guidance, the SYNCELL team is advancing the Microscoop product development and business strategy to realize SYNCELL’s vision to become a dominant player in spatial omics. Dr Liao takes a precision synergy approach to create a cooperative and efficient culture suitable for multidisciplinary communication. Having been immersed in the high-tech spinoff environment at MIT, Cal Berkeley, Stanford, and Columbia, he shapes SYNCELL to match the high caliber and advance toward a leading global life science equipment company.